by Mark Curtis | Sep 30, 2015
. Welcome to your cell therapy deal review for the month of August. Synthetic biology giant Intrexon closed a large financing; Immune Design announced a collaboration to pair its viral-based immunotherapy platform with a checkpoint inhibitor; and, NantKwest received a...
by Mark Curtis | Dec 4, 2014
. The Edmonton Protocol for the transplantation of insulin producing cells into individuals with type 1 diabetes (T1DM) has a cost per quality-adjusted life year (QALY) of ~$165,000. This is more than three times the willingness-to-pay (WTP) in Canada, and comfortably...
by Stacey Johnson | Apr 4, 2014
. This intriguing title is not completely my own. It is a shorter version of Alysson Muotri’s (UCSD) title from a presentation he gave to the governing Board of the California Institute of Regenerative Medicine on March 13, 2014: “Reversing Autism in the Lab with...
by Lisa Willemse | Jan 31, 2014
> By now, most readers will be familiar with this week’s announcement of a remarkable new discovery that mouse cells were made pluripotent using a relatively simple and quick acid bath technique. For those who aren’t, there’s reams of coverage,...
by Angela C. H. McDonald | Oct 16, 2012
I periodically indulge myself in the personal lives of the Seattle Grace Hospital staff on Grey’s Anatomy. I am particularly fond of the character Dr. Addison Montgomery, world-class neo-natal surgeon. After enduring some juicy relationship drama, Addison decides to...
Comments